Roburin DCAS# 136199-93-4 |
- Roburin A
Catalog No.:BCN0805
CAS No.:132864-75-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 136199-93-4 | SDF | Download SDF |
PubChem ID | 101998420 | Appearance | Powder |
Formula | C82H50O51 | M.Wt | 1851.2 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2R,20R,42S,46S)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-hexadecahydroxy-15-[(1R,2R,20R,42S,46S)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-4,17,22,40,44-pentaoxo-3,18,21,41,43-pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-pentadecaen-46-yl]-3,18,21,41,43-pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-pentadecaene-4,17,22,40,44-pentone | ||
SMILES | C1C2C(C3C4C(C5=C(C(=C(C(=C5C(=O)O4)C6=C(C(=C(C(=C6C(=O)O3)C7=C(C(=C(C=C7C(=O)O2)O)O)O)O)O)O)O)O)O)C8=C(C(=C(C9=C8C(=O)OCC2C(C3C4C(C5=C(C(=C(C(=C5C(=O)O4)C4=C(C(=C(C(=C4C(=O)O3)C3=C(C(=C(C=C3C(=O)O2)O)O)O)O)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C29)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O1)O)O)O)O)O)O | ||
Standard InChIKey | QTCMAUFCWPWEDU-XAOVTHGKSA-N | ||
Standard InChI | InChI=1S/C82H50O51/c83-13-1-8-20(46(93)41(13)88)21-9(2-14(84)42(89)47(21)94)76(117)128-67-18(6-124-73(8)114)126-74(115)10-3-15(85)43(90)48(95)22(10)26-36-28(54(101)62(109)52(26)99)29-38-33(59(106)65(112)55(29)102)34(69(130-79(38)120)71(67)132-80(36)121)32-35-25(51(98)64(111)58(32)105)24-12(5-17(87)45(92)50(24)97)77(118)129-68-19(7-125-78(35)119)127-75(116)11-4-16(86)44(91)49(96)23(11)27-37-30(56(103)63(110)53(27)100)31-39-40(60(107)66(113)57(31)104)61(108)70(131-82(39)123)72(68)133-81(37)122/h1-5,18-19,34,61,67-72,83-113H,6-7H2/t18-,19-,34+,61+,67-,68-,69+,70+,71+,72+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Roburin D Dilution Calculator
Roburin D Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.5402 mL | 2.701 mL | 5.4019 mL | 10.8038 mL | 13.5048 mL |
5 mM | 0.108 mL | 0.5402 mL | 1.0804 mL | 2.1608 mL | 2.701 mL |
10 mM | 0.054 mL | 0.2701 mL | 0.5402 mL | 1.0804 mL | 1.3505 mL |
50 mM | 0.0108 mL | 0.054 mL | 0.108 mL | 0.2161 mL | 0.2701 mL |
100 mM | 0.0054 mL | 0.027 mL | 0.054 mL | 0.108 mL | 0.135 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Roburin C
Catalog No.:BCN0807
CAS No.:137490-45-0
- Roburin B
Catalog No.:BCN0806
CAS No.:137370-65-1
- Roburin A
Catalog No.:BCN0805
CAS No.:132864-75-6
- Gambogoic acid A
Catalog No.:BCN0804
CAS No.:8879-23-49-1
- Moreollic acid
Catalog No.:BCN0803
CAS No.:173792-68-2
- Epigambogellic acid
Catalog No.:BCN0802
CAS No.:1352191-85-5
- Cannabisin M
Catalog No.:BCN0801
CAS No.:1831134-13-4
- 11beta,13-Dihydrolactucin
Catalog No.:BCN0800
CAS No.:83117-63-9
- 2-Phenylethyl-beta-glucopyranoside
Catalog No.:BCN0799
CAS No.:18997-54-1
- Naringenin 7-O-gentiobioside
Catalog No.:BCN0798
CAS No.:104154-33-8
- Umbelliferone 7-O-rutinoside
Catalog No.:BCN0797
CAS No.:135064-04-9
- Jacquilenin
Catalog No.:BCN0796
CAS No.:7726-34-3
- Roburin E
Catalog No.:BCN0809
CAS No.:137343-79-4
- Agathisflavone
Catalog No.:BCN0810
CAS No.:28441-98-7
- Rhusflavanone
Catalog No.:BCN0811
CAS No.:53060-72-3
- Elgonica dimer A
Catalog No.:BCN0813
CAS No.:132210-48-1
- 4-Methoxybenzoylacetic acid
Catalog No.:BCN0814
CAS No.:13422-77-0
- Cajanine
Catalog No.:BCN0815
CAS No.:87402-84-4
- Senkyunolide N
Catalog No.:BCN0816
CAS No.:140694-58-2
- Dehydrodicatechin A
Catalog No.:BCN0817
CAS No.:36048-23-4
- Barbaloin-related compound A
Catalog No.:BCN0818
CAS No.:473225-21-7
- Barbaloin-related compound B
Catalog No.:BCN0819
CAS No.:473225-22-8
- 3beta-(alpha-L-Arabinopyranosyloxy)urs-12,18-dien-28-oic acid beta-D-glucopyranosyl ester
Catalog No.:BCN0820
CAS No.:435269-07-1
- 3beta-Hydroxyurs-12,18-dien-28-oic acid beta-D-glucopyranosyl ester
Catalog No.:BCN0821
CAS No.:434942-42-4
C-glucosidic ellagitannins and galloylated glucoses as potential functional food ingredients with anti-diabetic properties: a study of alpha-glucosidase and alpha-amylase inhibition.[Pubmed:31927321]
Food Chem. 2020 May 30;313:126099.
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia, which can be counteracted by inhibition of alpha-glucosidase and alpha-amylase, both involved in the carbohydrate metabolism. Fourteen C-glucosidic ellagitannins and three galloylated glucoses were studied as potential alpha-glucosidase and alpha-amylase inhibitors. Most of the compounds were found to be moderate inhibitors of alpha-amylase, but potent inhibitors of alpha-glucosidase, showing low-micromolar IC50 values, far lower than that of the antidiabetic drug acarbose. This selectivity can be an advantage for their possible application as functional food ingredients with anti-diabetic properties because strong alpha-amylase inhibition generally causes undesired side effects. The best inhibitors were selected for further studies. Intrinsic fluorescence measurements confirmed their high affinity towards alpha-glucosidase, highlighting a static quenching mechanism. Circular dichroism measurements and kinetics of inhibition indicated that the most active C-glucosidic ellagitannin Roburin D (RobD) is a competitive inhibitor, whereas alpha-pentagalloylglucose (alpha-PGG) acts as a mixed-type inhibitor.
Identification and sensory evaluation of dehydro- and deoxy-ellagitannins formed upon toasting of oak wood (Quercus alba L.).[Pubmed:17444655]
J Agric Food Chem. 2007 May 16;55(10):4109-18.
Traditionally, spirits such as whiskey are matured in toasted wood barrels to improve the sensory quality of the final beverage. In order to gain first insight into the puzzling road map of thermal ellagitannin transformation chemistry and provide evidence for the changes in sensory active nonvolatiles in oak wood during toasting, the purified oak ellagitannins castalagin and vescalagin, their corresponding dimers roburin A and Roburin D, and 33-carboxy-33-deoxyvescalagin were thermally treated in model experiments. Besides mouth-coating and golden-brown colored melanoidin-type polymers, individual major reaction products were produced as transient intermediates which were identified for the first time by means of LC-MS/MS and 1D/2D-NMR spectroscopy. Depending strongly on the stereochemistry, castalagin is oxidized to the previously unreported dehydrocastalagin, whereas its diastereomer vescalagin, differing only in the stereochemistry at carbon C-1, is most surprisingly converted into deoxyvescalagin. Comparative model experiments with 33-carboxy-33-deoxyvescalagin revealed castalagin, vescalagin, dehydrocastalagin, and deoxyvescalagin as typical reaction products, thus indicating decarboxylation as a key step in the thermal degradation of that ellagitannin. Similar to the ellagitannin monomers, LC-MS/MS analyses gave strong evidence that the corresponding dimer roburin A, containing the vescalagin configuration at C-1, was converted into the deoxyroburin A, whereas Roburin D, exhibiting the castalagin configuration at C-1, was oxidized to give the dehydroRoburin D. Human sensory experiments revealed that the ellagitannin derivatives imparted an astringent mouth-coating sensation with threshold concentrations ranging from 1.1 to 126.0 micromol/L, depending strongly on their chemical structure.
Main structural and stereochemical aspects of the antiherpetic activity of nonahydroxyterphenoyl-containing C-glycosidic ellagitannins.[Pubmed:17191843]
Chem Biodivers. 2004 Feb;1(2):247-58.
Antiherpetic evaluation of five nonahydroxyterphenoyl-containing C-glycosidic ellagitannins, castalagin (1), vescalagin (2), grandinin (3), roburin B (5), and Roburin D (7), was performed in cultured cells against four HSV-1 and HSV-2 strains, two of which were resistant to Acyclovir. All five ellagitannins displayed significant anti-HSV activities against the Acyclovir-resistant mutants, but the monomeric structures 1-3 were more active than the dimers 5 and 7. Vescalagin (2) stands out among the five congeners tested as the most potent and selective inhibitor, with an IC50 value in the subfemtomolar range and a selectivity index 5x10(5) times higher than that of Acyclovir. Molecular modeling was used to provide a rationale for the surprisingly lower activity profile of its epimer castalagin (1). These ellagitannins have promising potential as novel inhibitors in the search for non-nucleoside drugs active against Acyclovir-resistant herpes viruses.